Vancomycin-resistant enterococci. Mechanism and clinical relevance (Q41676884)

6 October 2017

1 reference

title

Vancomycin-resistant enterococci. Mechanism and clinical relevance (English)

1 reference

6 October 2017

Eliopoulos GM

1

1 reference

6 October 2017

1 December 1997

1 reference

Infectious Disease Clinics of North America

6 October 2017

1 reference

6 October 2017

11

1 reference

6 October 2017

4

1 reference

6 October 2017

851-865

1 reference

The VanS sensor negatively controls VanR-mediated transcriptional activation of glycopeptide resistance genes of Tn1546 and related elements in the absence of induction

6 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

The vanZ gene of Tn1546 from Enterococcus faecium BM4147 confers resistance to teicoplanin.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

Quantitative analysis of the metabolism of soluble cytoplasmic peptidoglycan precursors of glycopeptide-resistant enterococci

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

Structural relationship between the vancomycin resistance protein VanH and 2-hydroxycarboxylic acid dehydrogenases

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

Specificity of induction of glycopeptide resistance genes in Enterococcus faecalis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

Farm animals as a putative reservoir for vancomycin-resistant enterococcal infection in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

Dimerization and membrane anchors in extracellular targeting of vancomycin group antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

Modification of peptidoglycan precursors is a common feature of the low-level vancomycin-resistant VANB-type Enterococcus D366 and of the naturally glycopeptide-resistant species Lactobacillus casei, Pediococcus pentosaceus, Leuconostoc mesenteroide

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

Controlling vancomycin-resistant enterococci

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

Effective treatment of multidrug-resistant enterococcal experimental endocarditis with combinations of cell wall-active agents

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

Identification of vancomycin resistance protein VanA as a D-alanine:D-alanine ligase of altered substrate specificity.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

Molecular basis for vancomycin resistance in Enterococcus faecium BM4147: biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

Comparison of different beta-lactam-glycopeptide-gentamicin combinations for an experimental endocarditis caused by a highly beta-lactam-resistant and highly glycopeptide-resistant isolate of Enterococcus faecium

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

Glycopeptide-resistant enterococci isolated from uncooked meat

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

Use of bacitracin therapy for infection due to vancomycin-resistant Enterococcus faecium

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

Superinfection with Enterococcus faecalis during quinupristin/dalfopristin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

Emergence of increased resistance to quinupristin/dalfopristin during therapy for Enterococcus faecium bacteremia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

Resistance of enterococci to glycopeptides

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

Presence of vancomycin-resistant enterococci in farm and pet animals

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

Emergence of high-level resistance to glycopeptides in Enterococcus gallinarum and Enterococcus casseliflavus

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

Vancomycin-resistant enterococcal bacteremia: natural history and attributable mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

Regulation of VanB-type vancomycin resistance gene expression by the VanS(B)-VanR (B) two-component regulatory system in Enterococcus faecalis V583

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

The vanB gene of vancomycin-resistant Enterococcus faecalis V583 is structurally related to genes encoding D-Ala:D-Ala ligases and glycopeptide-resistance proteins VanA and VanC.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

Emergence of vancomycin-resistant enterococci in New York City

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

Vancomycin-resistant enterococci colonizing the intestinal tracts of hospitalized patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

Vancomycin-resistant Leuconostoc mesenteroides and Lactobacillus casei synthesize cytoplasmic peptidoglycan precursors that terminate in lactate

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

Identification of chromosomal mobile element conferring high-level vancomycin resistance in Enterococcus faecium

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

Heterogeneity of the vanA gene cluster in clinical isolates of enterococci from the northeastern United States

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

In vivo development of teicoplanin resistance in a VanB Enterococcus faecium isolate.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

Emerging multiply resistant enterococci among clinical isolates. I. Prevalence data from 97 medical center surveillance study in the United States. Enterococcus Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

Enterococcus faecium strains with vanA-mediated high-level glycopeptide resistance isolated from animal foodstuffs and fecal samples of humans in the community.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

vanA-mediated high-level glycopeptide resistance in Enterococcus faecium from animal husbandry

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

The challenge of vancomycin-resistant enterococci: a clinical and epidemiologic study.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

Enterococci acquire new kinds of resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

Relative importance of oral versus intravenous vancomycin exposure in the development of vancomycin-resistant enterococci

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

Successful treatment of persistent bacteremia due to vancomycin-resistant, ampicillin-resistant Enterococcus faecium

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

Natural history of colonization with vancomycin-resistant Enterococcus faecium

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

Effect of novobiocin-containing antimicrobial regimens on infection and colonization with vancomycin-resistant Enterococcus faecium

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

Clinical and molecular epidemiology of vancomycin-resistant Enterococcus faecium during its emergence in a city in southern Texas.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

Enterococci resistant to multiple antimicrobial agents, including vancomycin. Establishment of endemicity in a university medical center

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

What can we do about vancomycin-resistant enterococci?

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

Analysis of genes encoding D-alanine-D-alanine ligase-related enzymes in Enterococcus casseliflavus and Enterococcus flavescens

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

Chloramphenicol for the treatment of vancomycin-resistant enterococcal infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

Recovery of vancomycin-resistant enterococci on fingertips and environmental surfaces.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

Enteric eradication of vancomycin-resistant Enterococcus faecium with oral bacitracin

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients: risk factors for acquisition and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

vanA genes in vancomycin-resistant clinical isolates of Oerskovia turbata and Arcanobacterium (Corynebacterium) haemolyticum.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

Emergence of vancomycin resistance in the genus Streptococcus: characterization of a vanB transferable determinant in Streptococcus bovis.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

Conjugal transfer of the vancomycin resistance determinant vanB between enterococci involves the movement of large genetic elements from chromosome to chromosome

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

The vanB gene confers various levels of self-transferable resistance to vancomycin in enterococci.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

Glycopeptide resistance mediated by enterococcal transposon Tn1546 requires production of VanX for hydrolysis of D-alanyl-D-alanine.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

Analysis of peptidoglycan precursors in vancomycin-resistant Enterococcus gallinarum BM4174

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

Inducible and constitutive expression of resistance to glycopeptides and vancomycin dependence in glycopeptide-resistant Enterococcus avium

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

Inducible and constitutive expression of vanC-1-encoded resistance to vancomycin in Enterococcus gallinarum

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

Household transmission of vancomycin-resistant Enterococcus faecium

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

Risk factors associated with vancomycin-resistant Enterococcus faecium infection or colonization in 145 matched case patients and control patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

van A-Mediated vancomycin-resistant Enterococcus spp. in sewage

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

Influence of oral glycopeptides on the fecal flora of human volunteers: selection of highly glycopeptide-resistant enterococci

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

The emergence of Enterococcus faecium resistant to glycopeptides and other standard agents--a preliminary report.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

A citywide survey of vancomycin-resistant Enterococcus--New York City, 1993.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

Stool Carriage, Clinical Isolation, and Mortality During an Outbreak of Vancomycin-Resistant Enterococci in Hospitalized Medical and/or Surgical Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

Gastrointestinal tract colonization with vancomycin-resistant Enterococcus faecium in an animal model.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

Glycopeptide-resistant Enterococcus faecium outside Hospitals: a commentary.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

Overexpression, purification, and characterization of VanX, a D-, D-dipeptidase which is essential for vancomycin resistance in Enterococcus faecium BM4147.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

Treatment of experimental endocarditis due to multidrug-resistant Enterococcus faecium with clinafloxacin and penicillin

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970393-7

7 January 2021

10.1016/S0891-5520(05)70393-7

Identifiers

DOI

1 reference

6 October 2017

1 reference

PubMed ID

9421703